Serotonin-1b agonists induce compartmentally organized striatal Fos expression in rats

NeuroReport

Volumn 9, Issue 6, 1998, Pages 1217-1221

  Wirtshafter, David ^a   Cook, David F ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

5 HT(1B) receptor; Anpirtoline; c Fos; Immediate early genes; RU24969; Serotonin; Striatum; Striosomes

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; ANPIRTOLINE; BEMESETRON; OPIATE RECEPTOR; PROTEIN C FOS; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1B AGONIST; SEROTONIN 3 ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION REGULATION; IMMEDIATE EARLY GENE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROMODULATION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032550119     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199804200-00047     Document Type: Article

References (25)

1. Li B-H and Rowland NE. Brain Res 728, 188-192 (1996).
2. Rouillard C, Bovetto S, Gervais J et al. Mol Brain Res 37, 105-115 (1996).
3. Torres G and Rivier C. Brain Res 647, 1-9 (1994).
4. Moorman JM, Jackson A, Grahame-Smith DG et al. Neuroscience 68, 1089-1096 (1997).
5. Bhat RV and Baraban JM. J Pharmacol Exp Ther 267, 496-505 (1993).
6. Moorman JM, and Leslie RA. Neuroscience 72, 129-139 (1996).
7. Leslie RA, Moorman JM, Coulson A et al. Neuroscience 53, 457-463 (1993).
8. Middlemiss DN and Hutson PH. Ann NY Acad Sci 600, 132-148 (1990).
9. Boulenguez P, Rawlins JNP, Chauveau J et al. Neuropharmacology 35, 1521-1529 (1996).
10. Hoyer D. Life Sci 8, 1-4 (1988).
11. Lucas JJ, Koester J and Hen R. Soc Neurosci Abstr 21, 715 (1995).
12. Kalkman HO. Arch Pharmacol 352, 583-584 (1995).
13. Doods HN, Kalkman HO, De Jonge A et al. Eur J Pharmacol 112, 363-370 (1985).
14. Thielen RJ, Fangon NB and Frazer A. J Pharmacol Exp Ther 277, 662-670 (1996).
15. Allen AR, Singh A, Zhuang ZP et al. Pharmacol Biochem Behav 57, 301-307 (1997).
16. Schlicker E, Werner U, Hamon M et al. Br J Pharmacol 105, 732-738 (1992).
17. Gothert M, Hamon M, Barann M et al. Br J Pharmacol 114, 269-274 (1995).
18. Swedbert MDB, Shannon HE, Nickel B et al. J Pharmacol Exp Ther 263, 1015-1022 (1992).
19. Cook DF, and Wirtshafter D. Soc Neurosci Abstr 21, 1424 (1995).
20. Wirtshafter D and Asin KE. Brain Res Bull 35, 85-91 (1994).
21. Compaan JC, Groenink L, van der Gugten J et al. Eur J Neurosci 8, 2340-2347 (1996).
22. Johansson B, Lindstrom K and Fredholm BB. Neuroscience 59, 837-849 (1994).
23. Asin KE, Wirtshafter D and Nikkel A. Brain Res 719, 138-142 (1996).
24. Graybiel AM, Moratalla R and Robertson HA. Proc Natl Acad Sci USA 87, 6912-6916 (1990).
25. Galloway MP, Suchowski CS, Keegan MJ et al. Synapse 15, 90-92 (1993).